Trials / Unknown
UnknownNCT01919866
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells
Haploidentical Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells in Pediatric Patients With Refractory Hematological and Oncological Diseases
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University Children's Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 1 Year – 25 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility and toxicity of haploidentical transplantation of CD3/CD19 depleted stem cells in combination with a toxicity reduced conditioning regimen or with standard conditioning regimens according to underlying disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Transplantation of CD3/CD19 depleted stem cells |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2013-08-09
- Last updated
- 2014-10-08
Locations
5 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01919866. Inclusion in this directory is not an endorsement.